| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |